Do you want to read an article? Please log in or register.
Methodologic Issues With Comparative Effectiveness Study on LAMA-LABA-ICS vs LAMA-LABA for the Treatment of COPD in the Clinical Practice Research Datalink
COPD
RECOMMENDED
Related content
RECOMMENDED
COPD
Comparative effects of LAMA-LABA-ICS versus LAMA-LABA for COPD: Cohort study in real world clinical practice: LAMA-LABA-ICS versus LAMA-LABA in COPD
★ 3
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Chest.
Suissa S, Dell'Aniello S, Ernst P
doi: 10.1016/j.chest.2019.11.007.
RECOMMENDED
COPD
Methodologic Issues With Comparative Effectiveness Study on LAMA-LABA-ICS vs LAMA-LABA for the Treatment of COPD in the Clinical Practice Research Datalink
★ 1
Recommended by
Dr Martin Frey, Faculty Member
Chest
Rothnie KJ, Quint JK
doi: 10.1016/j.chest.2020.02.069
RECOMMENDED
COPD
Comparative effectiveness of LABA-ICS versus LAMA as initial treatment in COPD targeted by blood eosinophils: a population-based cohort study
Lancet Respir Med.
Suissa S, Dell'Aniello S, Ernst P
doi: 10.1016/S2213-
RECOMMENDED
COPD
Dual LABA/LAMA Therapy versus LABA or LAMA Monotherapy for COPD: A Systematic Review and Meta-analysis in Support of the American Thoracic Society Clinical Practice Guideline
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Ann Am Thorac Soc.
Mammen MJ, Pai V, Aaron SD, Nici L, Alhazzani W, Alexander PE
doi: 10.1513/AnnalsATS.201912-915OC.
RECOMMENDED
COPD
Comparing initial LABA-ICS inhalers in COPD: Real-world effectiveness and safety
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Respir Med
Suissa S, Dell'Aniello S, Ernst P
doi: 10.1016/j.rmed.2021.106645
RECOMMENDED
COPD
Benefit and safety of fluticasone furoate/vilanterol in the Salford Lung Study in chronic obstructive pulmonary disease (SLS COPD) according to baseline patient characteristics and treatment subgroups
Respir Med.
Bakerly ND, Woodcock A,
Collier S, Leather DA, New JP,
Crawford J, Harvey C, Vestbo J,
Boucot I
doi: 10.1016/j.rmed.2018.12.016.
RECOMMENDED
COPD
Improving the evaluation of COPD exacerbation treatment effects by accounting for early treatment discontinuations: a post-hoc analysis of randomized clinical trials
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Respir Res.
Król A, Palmér R, Rondeau V, Rennard S, Eriksson UG, Jauhiainen A
doi: 10.1186/s12931-020-01419-8.
RECOMMENDED
COPDPneumonia
Real world effects of COPD medications: a cohort study with validation against RCT results
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Eur Respir J.
Wing K, Williamson E, Carpenter JR, Wise L, Schneeweiss S, Smeeth L, Quint JK, Douglas I
doi: 10.1183/13993003.01586-2020. Visit the original publication at ncbi.nlm.nih.gov
Effectiveness of fluticasone furoate plus vilanterol on asthma control in clinical practice: an open-label, parallel group, randomised controlled trial
Read the comment: Effectiveness trials in asthma: time to SaLSA? >>>
doi: 10.1016/